Abstract:Background: The E3 ubiquitin ligase casitas B-lineage lymphoma-b (CBLB) is a newly identified component of the ubiquitin-dependent protein degradation system and is considered an important negative regulator of immune cells. CBLB is essential for establishing a threshold of T-cell activation and regulating peripheral T-cell tolerance through various mechanisms. However, the involvement of CBLB in the pathogenesis of immune thrombocytopenia (ITP) is unknown. Objectives: We aimed to investigate the expression and role of CBLB in CD4+ T cells obtained from patients with ITP through quantitative proteomics analyses. Methods: CD4+ T cells were transfected with adenoviral vectors overexpressing CBLB to clarify the effect of CBLB on anergic induction of T cells in patients with ITP. DNA methylation levels of the CBLB promoter and 5' untranslated region (UTR) in patient-derived CD4+ T cells were detected via MassARRAY EpiTYPER assay (Agena Bioscience). Results: CD4+ T cells from patients with ITP showed resistance to anergic induction, highly activated phosphoinositide 3-kinase-protein kinase B (AKT) signaling, decreased CBLB expression, and 5' UTR hypermethylation of CBLB. CBLB overexpression in T cells effectively attenuated the elevated phosphorylated protein kinase B level and resistance to anergy. Low-dose decitabine treatment led to significantly elevated levels of CBLB expression in CD4+ T cells from 7 patients showing a partial or complete response. Conclusion: These results indicate that the 5' UTR hypermethylation of CBLB in CD4+ T cells induces resistance to T-cell anergy in ITP. Thus, the upregulation of CBLB expression by low-dose decitabine treatment may represent a potential therapeutic approach to ITP.

Negative Regulation of Cd40-Mediated B Cell Responses by E3 Ubiquitin Ligase Casitas-B-Lineage Lymphoma Protein-B

Differential Regulation of the B Cell Receptor-mediated Signaling by the E3 Ubiquitin Ligase Cbl

Ablation of Cbl-b and C-Cbl in Dendritic Cells Causes Spontaneous Liver Cirrhosis Via Altering Multiple Properties of CD103+ Cdc1s

Aberrant CD40-Induced NF-κB Activation in Human Lupus B Lymphocytes

Negative Regulation of T Cell Antigen Receptor-Mediated Crk-L-C3G Signaling and Cell Adhesion by Cbl-b.

Cbl and Cbl-b in T-cell Regulation.

NF-κB Downregulates Cbl-b Through Binding and Suppressing Cbl-b Promoter in T Cell Activation.

E3 Ubiquitin Ligase Cbl-b Negatively Regulates C-type Lectin Receptor–mediated Antifungal Innate Immunity

T Cell Costimulation through CD28 Depends on Induction of the Bcl-xγ Isoform

T cell costimulation through CD28 depends on induction of the Bcl-xgamma isoform: analysis of Bcl-xgamma-deficient mice.

Regulation of Bcl-Xl Expression and Fas Susceptibility in Mouse B Cells by CD40 Ligation, Surface IgM Crosslinking and IL-4.

Up-Regulation of Cbl-B is Associated with Lsectin-Mediated Inhibition of Different Cd4(+) T-Cell Subsets

Cbl-b restrains priming of pathogenic Th17 cells via the inhibition of IL-6 production by macrophages

Cbl-b inhibited CD4+T cell activation by regulating the expression of miR-99a/miR-125b

E3 ubiquitin ligase casitas B-lineage lymphoma-b modulates T-cell anergic resistance via phosphoinositide 3-kinase signaling in patients with immune thrombocytopenia

Act1, a Negative Regulator in CD40- and BAFF-mediated B Cell Survival.

CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L. Potential role in regulating helper effector function.

Overproduction of IFNγ by Cbl-b–Deficient CD8+ T Cells Provides Resistance against Regulatory T Cells and Induces Potent Antitumor Immunity

Constitutively CD40-activated B cells regulate CD8 T cell inflammatory response by IL-10 induction.

Integrin ITGAM/CD11b Negatively Regulates BCR Signaling to Maintain Autoreactive B Cell Tolerance (P4062)